Reconstructing protein conformations to activate follicular enzyme-nutrient reservoirs for reversing follicle aging Authors: Shifeng Ling, Mingyue Liu, Chen Meng, Kaifeng Huo, Yida Wang, Yixiang Zhang, Yingying Wei, Lucia Zhou, Yawei Du, Wenguo Cui Published: 2026 ABSTRACT Hair regeneration depends on a reservoir of follicular enzymes that regulate the microenvironment and provide metabolic support. However, in degenerative alopecia, this enzymatic reservoir is disrupted, impairing microenvironmental homeostasis. Here, through bioinformatics and molecular dynamics analyses, we revealed that several Zn2+/Cu2+-dependent proteases (e.g., LOX and SOD1) were downregulated and exhibit aberrant conformations and activities in degenerative alopecia, further weakening microenvironmental support. To address this, we developed a Zn2+/Cu2+-doped decellularized extracellular matrix microneedle patch (dECMMAZn/Cu) to rapidly restore the follicular microenvironment and enzymatic reservoir function. In vitro, microneedle delivery of dECMMAZn/Cu significantly upregulated key Zn2+/Cu2+-dependent proteases. Restoration of the enzymatic reservoir reduced p16 expression in dermal papilla stem cells, inhibited cellular senescence, and promoted stem cell proliferation. In a classical degenerative alopecia animal model, dECMMAZn/Cu microneedle treatment resulted in denser and more continuous dermal collagen, a significant increase in hair follicle numbers, and promoted hair regeneration. In summary, this study establishes an innovative microneedle material that restores follicular function by remodeling protein conformation and activating the enzymatic reservoir. Introduction Hair regeneration relies on a reservoir of follicular enzymes that maintain the microenvironment and provide metabolic support [[1], [2], [3]]. This enzymatic reservoir is essential for regulating follicle aging by sustaining stem cell function and microenvironmental homeostasis. Among these enzymes, metalloproteases play a particularly critical role [4]. Their activity depends on metal ion-mediated conformational stability. However, aging or prolonged external stress reduces protein stability, leading to metalloprotease inactivation, disruption of catalytic centers and substrate recognition, and ultimately impaired extracellular matrix (ECM) remodeling and stem cell niche function [[5], [6], [7], [8]]. Current treatments, such as minoxidil and finasteride, mainly target hormonal pathways and have limited efficacy, as they do not address the underlying loss of enzymatic function caused by conformational destabilization [[9], [10], [11]]. Conventional protein delivery and trace-element supplementation fall short of fully reactivating the enzymatic reservoir. Furthermore, clinical application is challenged by poor transdermal delivery, uneven distribution, and limited tissue penetration. Therefore, innovative strategies are urgently needed to address both follicular microenvironmental aging and enzymatic reservoir dysfunction (see Scheme 1).Scheme 1Schematic illustration of the Zn2+/Cu2+-doped decellularized extracellular matrix microneedle system (dECMMAZn/Cu) to for reversing follicle aging. Upon transdermal application, the in situ delivery of decellularized extracellular matrix would rapidly restore the follicular microenvironment via extracellular matrix (ECM) remodeling. And Zn2+/Cu2+ delivery could restore enzymatic reservoir function via protein conformation reconstruction. Ultimately, dECMMAZn/Cu reversed follicular microenvironmental aging and promoted hair regeneration. Schematic illustration of the Zn2+/Cu2+-doped decellularized extracellular matrix microneedle system (dECMMAZn/Cu) to for reversing follicle aging. Upon transdermal application, the in situ delivery of decellularized extracellular matrix would rapidly restore the follicular microenvironment via extracellular matrix (ECM) remodeling. And Zn2+/Cu2+ delivery could restore enzymatic reservoir function via protein conformation reconstruction. Ultimately, dECMMAZn/Cu reversed follicular microenvironmental aging and promoted hair regeneration. Enzyme activity depends on their conformational structure, especially for metalloproteases with metal ions at their active centers, where conformational stability is critical for catalytic function. Metalloproteases typically exist as inactive zymogens and require metal-induced conformational changes to transition into their active forms [12]. These ions coordinate with amino acid residues (e.g., histidine, cysteine) to alter the metalloprotease conformation, stabilize catalytic domains, and enhance substrate binding and catalytic efficiency. Importantly, Zn2+ and Cu2+ primarily regulate enzyme activity through coordination-mediated conformational stabilization rather than directly increasing enzyme expression, thereby restoring catalytic competence in metalloproteases. For example, zinc is a core cofactor in matrix metalloproteinases (MMPs), especially MMP-2 and MMP-9, which are cyclically expressed in follicles to regulate ECM remodeling [[13], [14], [15], [16]]. MMP-9 is significantly upregulated during follicle regression and requires zinc to maintain its catalytic domain structure [17]. Similarly, copper is essential for lysyl oxidase (LOX) activity, facilitating collagen and elastin crosslinking, enhancing ECM mechanical stability, and supporting follicle reconstruction [18]. Importantly, the follicular enzymatic reservoir is highly sensitive to local ion concentrations. These metal ions not only serve as essential cofactors but also act as triggers for conformational activation. Their mechanisms can be summarized as: (1) structural stabilizers that promote folding or stabilize active states [19,20]; and (2) catalytic cofactors that enhance substrate-induced fit, boosting reaction specificity and efficiency [21,22]. Based on this mechanism, recent research has focused on ion-induced activation strategies for hair regeneration. Controlled local delivery of metal ions can restore the conformational and functional states of key proteases, enabling ECM renewal and follicle regeneration. Precisely regulating ion concentrations and their timing in the follicular microenvironment is thus crucial for reversing hair loss and offers new avenues for conformation-driven protein activation therapies. There is a significant skin barrier that limits efficient follicular delivery. Recently, microneedle (MN) patches have emerged as a promising strategy for transdermal drug delivery and microenvironmental regulation [10,[23], [24], [25], [26]]. Their micron-scale needle tips can penetrate the stratum corneum to enable localized, sustained drug release, improving therapeutic efficacy and minimizing systemic side effects. Compared to topical or oral routes, MNs allow direct dermal delivery, enhancing local drug concentration, especially useful for inflammation, regeneration, and ECM repair [[27], [28], [29], [30]]. Conventional MNs are typically made from biodegradable (e.g., PLA, PCL) or natural polymers (e.g., hyaluronic acid, gelatin), offering biocompatibility and fabrication flexibility. However, most current systems focus on single-drug delivery and cannot meet the complex requirements of the aging follicular stem cell niche. Hair follicle aging is accompanied by ECM degradation, signaling disruption, and stem cell dysfunction, necessitating materials with enhanced bioactivity and structural support [[31], [32], [33]]. Decellularized extracellular matrix (dECM) holds great potential due to its preserved bioactive components and native ECM signals [[34], [35], [36], [37], [38]]. Integrating dECM into MNs provides a biomimetic scaffold for stem cells, promoting adhesion, migration, and differentiation via endogenous growth factor release [39]. However, native dECM suffers from poor mechanical strength and rapid degradation. To address these limitations, methacryloyl modification (dECMMA) introduces photopolymerizable methacrylate groups, enabling the formation of a crosslinked network under UV light, enhancing mechanical stability and controlled degradation [40,41]. Furthermore, doping with ions allows dynamic coordination with dECM functional groups (e.g., carboxyl, hydroxyl), creating a reinforced network with improved mechanics [39]. Such dECMMA-based microneedles thus offer a targeted and sustained solution for stem cell niche rejuvenation and follicular regeneration [42]. In this study, bioinformatics and molecular dynamics analyses revealed that several Zn2+/Cu2+-dependent metalloproteases, including LOX and SOD1, are downregulated and exhibit abnormal conformations and activities in degenerative alopecia, further impairing the follicular microenvironment. To address this, we developed a Zn2+/Cu2+-doped dECMMA microneedle patch (dECMMAZn/Cu), designed to rapidly restore the follicular microenvironment and enzymatic reservoir function. UV-induced crosslinking enhanced the mechanical strength of the microneedles, enabling them to effectively penetrate the stratum corneum and deliver both dECM and essential ions directly to the target site. In vitro, dECMMAZn/Cu treatment reduced p16 expression in dermal papilla stem cells, inhibited cellular senescence, and promoted proliferation. It also enhanced angiogenesis in hUVECs and facilitated macrophage polarization from a pro-inflammatory to an anti-inflammatory phenotype. In vivo, in a classical androgenetic alopecia (AGA) model, dECMMAZn/Cu microneedles activated Zn2+/Cu2+-dependent metalloproteases and significantly promoted hair regeneration within 14 days post-treatment. In summary, this study achieved the synchronous delivery of metal ions and dECM into the follicular microenvironment via a microneedle system, enabling rapid reconstruction of ECM structure and restoration of protease activity conformations. Ultimately, this approach reversed follicular aging and significantly promoted hair regeneration. Materials and methods Decellularized matrix methacrylation hydrogel and microneedle preparation Decellularized extracellular matrix (dECM) was prepared from mouse dorsal skin tissue. Briefly, skin tissues were harvested, and hair and subcutaneous fat were removed. The samples were treated with 1% SDS for 3-4 days with daily solution changes to remove cellular components, followed by isopropanol treatment to eliminate lipids. The tissues were extensively washed with deionized water to remove residual reagents, freeze-dried, and ground into powder for further use. dECM methacrylate (dECMMA) was synthesized according to a modified protocol based on previous reports. Briefly, purified dECM was dissolved in 0.5 M acetic acid at 4 °C overnight and adjusted to pH 8-9. Methacrylic anhydride was added dropwise under stirring and allowed to react for 48 h at 4 °C. The product was dialyzed against deionized water for 5-7 days, followed by freeze-drying to obtain dECMMA [[43], [44], [45]]. Metal ion-doped dECMMA precursor solutions were prepared by adding metal salts to the dECMMA solution. Specifically, CuSO4·5H2O (Sigma-Aldrich, MS) was added at 2% (w/v) for dECMMACu, ZnCl2 at 2% (w/v) for dECMMAZn, and CuSO4·5H2O plus ZnCl2 at 1% (w/v) each for dECMMAZn/Cu. The mixtures were stirred until homogeneous. For microneedle fabrication, 0.1% (w/v) LAP was added to the precursor solution, which was then cast into microneedle molds and exposed to UV light (365 nm, ∼8 mW/cm2) for 5 min to induce crosslinking. After curing, the microneedle patches were carefully removed. The resulting microneedle arrays consisted of a high-density circular arrangement of square pyramidal needles, with a height of approximately 850 μm, a base width of approximately 380 × 380 μm, and a tip diameter of approximately 15-20 μm. The center-to-center spacing between adjacent microneedles was approximately 600 μm. Each patch contained approximately 688 microneedles within an effective circular area of approximately 19 mm in diameter. Microneedle extracts were prepared by incubating fully crosslinked microneedles (≈0.07 g) in 100 mL of complete culture medium at 37 °C for 24 h, allowing swelling-induced degradation and release of loaded components. Fourier infrared (FTIR), X-ray diffraction (XRD), thermal stability (TGA) and X-ray photoelectron spectroscopy (XPS) The morphology of the prepared scaffolds was examined by digital camera (EOS 90D, Canon, Japan) and SEM (Nova NanoSEM 450, Thermo Fisher Scientific, Hillsboro, OR), and the elemental distribution in the scaffolds was examined by X-ray energy dispersive spectroscopy. Total reflection Fourier infrared (FTIR) spectroscopy was performed on dECM with a scanning wavelength range of 600 ∼ 3600 cm−1 For XRD analysis, the crystalline phase of the samples was detected using a Bruker AXS D8 Discover X-ray diffractometer at 2θ between 10° and 60°. A mass of 5 mg of FC-support with different contents was taken and placed in an alumina crucible, which was then placed in the TGA instrument. The program was set as follows: temperature: 700 °C, heating rate: 20 °C/min, protected by nitrogen gas. A certain amount of the scaffold was taken and the elemental composition of the scaffold was tested by X-ray photoelectron spectroscopy (XPS). dECM ion release assay In this study, we performed tests for the release of copper (Cu2+) and zinc (Zn2+) by incubating the samples at 37 °C in 0.9% saline. At predesigned time points, the incubation solution was collected for analysis and replaced with fresh saline. The concentrations of Cu2+ and Zn2+ (n = 3) were determined by inductively coupled plasma atomic emission spectroscopy (ICP-AES) (Prodigy Plus, Teledyne Leeman Labs, Hudson, NH). Extraction and culture of DPSCs The 4-week-old C57BL/6 mice were taken and killed by breaking the neck, the back hair trunk was shaved with a shaver, the dorsal skin of mice was sterilized with 75% ethanol, the whole dorsal skin was cut off, rinsed with PBS containing 1% penicillin-streptomycin for 3 times, and digested with 0.2% type I collagenase at 37 °C for 2 h, and the fat around the follicles and dermal tissues were removed. After rinsing 3 times with PBS, the dermis was scraped off the bulb of the hair follicle with scissors face upward, and then blown uniformly in PBS solution, centrifuged at 1000 rpm for 5 min to remove the supernatant, and then resuspended in whole culture (10% FBS + DMEM) and added to an equal amount of 9% Ficoll solution, and then centrifuged in a gradient of 200 rpm for 5 min to take the lower portion of the follicle, and then centrifuged at 1000 r/min for 5 min to take the sediment, and then added again to whole culture, and then mixed well. The whole culture was added again, mixed well and added to an equal amount of 9% Ficoll solution, centrifuged at 200 rpm gradient for 5 min, the upper part was taken, centrifuged at 800 rpm for 5 min, and the precipitate was taken for incubation. 48 h later, the solution was changed, and the cells were allowed to fuse to 90%, and then passaged culture was performed according to the 1:2. Cell culture and rationale for selection Dermal papilla stem cells (DPSCs), Raw264.7 macrophages, and HUVECs were used in this study. DPSCs were isolated from murine dorsal skin and maintained in DMEM (Life Sciences, Logan, UT) supplemented with 10% fetal bovine serum (Life Sciences, Logan, UT), and 1% penicillin-streptomycin (Beyotime, Shanghai, China). Raw 264.7 cells were cultured in DMEM (Life Sciences, Logan, UT) with 10% FBS and 1% penicillin-streptomycin at 37 °C in a humidified 5% CO2 incubator. HUVECs were cultured in DMEM (Life Sciences, Logan, UT) with 10% FBS and 1% penicillin-streptomycin at 37 °C in a humidified 5% CO2 incubator. The identity of HUVEC cells used in this study was authenticated by short tandem repeat (STR) profiling prior to experiments. The STR electropherogram and allele profiles are provided in Fig. S1 and Table S1. Cytotoxicity test After the cells were resuspended by trypsin digestion, they were inoculated into 24-well plates according to 20,000 cells/well, and after the cells were attached to the wall, 200 μL of Cell Counting Kit-8 (Beyotime, Shanghai, China) solution was added to each well after intervening under different conditions for 1, 4, and 7 days, and then incubated at 37 °C and protected from light for 2 h, and then the absorbance of the solution was measured using an enzyme counter at 450 nm. Staining of live and dead cells The cells were digested and resuspended with trypsin and then inoculated into 24-well plates at 20,000/well. After the cells were attached to the wall and intervened under different conditions for 1, 4 and 7 days, the cells were stained for live-dead cells using Calcein/PI Cell Activity and Cytotoxicity Assay Kit (Beyotime, Shanghai, China) according to the instructions. Briefly, the inoculated cells were gently washed with PBS for 3 times, and then each well was incubated with an appropriate amount of Calcein/PI working solution for 10 min at 37 °C, protected from light, and the live cells were observed using a fluorescence microscope, and the number of live and dead cells were counted using Image J. The cells were then stained with the Calcein/PI working solution for 10 min at 37 °C, protected from light [46]. SA-β-gal staining Cells were stained using Senescence β-Galactosidase Staining Kit (Beyotime, Shanghai, China) according to the instructions. Briefly, the cells were fixed with 4% paraformaldehyde, washed three times with PBS, and incubated overnight at 37 °C protected from light by adding SA-β-gal staining working solution. The next day, the cells were observed under an ordinary light microscope and photographed for recording. The number of positive cells was counted using Image J [47]. Quantitative real-time polymerase chain reaction (qRT-PCR) Total RNA was extracted using FreeZol Reagent (Vazyme, Nanjing, China) according to the instructions, cDNA was synthesized by reverse transcription using HiScript III RT SuperMix for qPCR (+gDNA wiper) (Vazyme, Nanjing, China), and qRT-PCR experiments were performed using ChamQ Universal SYBR The cDNA was synthesized by reverse transcription using ChamQ Universal SYBR Master Mix (Vazyme, Nanjing, China). qPCR Master Mix (Vazyme, Nanjing, China) was used to perform qRT-PCR experiments. The expression of target genes was normalized using GAPDH. The relative expression of the target genes was calculated using the 2−ΔΔCT method. At least three biological replicates were performed for each target gene. The primers used in the experiments are shown in Table S2. Immunofluorescence staining Cells were fixed with 4% paraformaldehyde for 15 min and then blocked with QuickBlock™ Blocking Buffer (Beyotime, Shanghai, China) for 30 min, followed by overnight incubation at 4 °C with primary antibodies including: anti-p16 antibody (rabbit polyclonal, 10883-1-AP, Proteintech, Wuhan, China), Anti-γ-H2AX (rabbit monoclonal, 83307-2-RR, Proteintech, Wuhan, China). On the next day, the cells were washed three times with PBS and incubated with goat anti-rabbit IgG H&L (Alexa Fluor 488, A0423, Beyotime, China) or goat anti-mouse IgG H&L (Alexa Fluor 488, A0428, Beyotime, China) for 1 h at room temperature. After incubation for 1 h at room temperature, Actin-Tracker Red-555 (C2203S, Beyotime, Shanghai, China) was added for 1h. Finally, DAPI (P0131, Beyotime, Shanghai, China) was added to stain the nuclei. The fluorescence images of the cells were taken using a laser confocal microscope, and the average fluorescence intensity or the number of positive cells in each group was counted using Image J. The average fluorescence intensity or the number of positive cells in each group was calculated using Image J. Western blot and immunohistochemistry Total protein was extracted after lysis of cells using RIPA. The total protein concentration was determined using the BCA kit (Beyotime Co., Shanghai, China), and after the target proteins were separated using SDS-PAGE (Beyotime Co., Shanghai, China), the target proteins were transferred to PVDF (Beyotime Co., Shanghai, China) membranes, and the PVDF membranes were blocked using QuickBlock™ Blocking Buffer (Beyotime Co., Shanghai, China) was used to seal the PVDF membrane for 30 min, followed by the addition of primary antibodies, including anti-p16 antibody (rabbit polyclonal, 10883-1-AP, Proteintech Co., Wuhan, China), GAPDH (mouse monoclonal, 60004-1-Ig, Proteintech, Wuhan, China), which were co-incubated at 4 °C overnight, and washed with Western Wash Buffer (Beyotime Co., Shanghai, China) for 3 times, and then the membrane was washed with HRP-conjugated Goat Anti-Mouse IgG (H + L) (SA00012-1, Proteintech Co., Wuhan, China) or HRP-conjugated Goat Anti-Rabbit IgG (H + L) (SA00001-2, Proteintech Co., Wuhan, China) secondary antibodies were incubated at room temperature for 1.5 h. The bands were visualized using an NcmECL Ultra (New Cell&Molecular Biotech. Co., Suzhou, China) enhanced chemiluminescence detection system. Cells were fixed with 4% paraformaldehyde for 15 min and then blocked with QuickBlock™ Blocking Buffer (Beyotime, Shanghai, China) for 30 min, followed by overnight incubation at 4 °C with a primary antibody consisting of: anti-CD206 antibody (1:50, Proteintech Co., Wuhan, China), anti-LOX (1:50, Proteintech Co., Wuhan, China), anti-SOD1 (1:50, Proteintech Co., Wuhan, China), anti-CD31 (1:50, Proteintech Co., Wuhan, China), anti-iNOS antibody (1:50, Proteintech Co., Wuhan, China), anti-p16 antibody (1:100, Proteintech Co., Wuhan, China). On the next day, the cells were washed three times with PBS and incubated with goat anti-rabbit IgG H&L (Alexa Fluor 488 or 594, Beyotime Co., Shanghai, China) or goat anti-mouse IgG H&L (Alexa Fluor 488 or 594, Beyotime Co., Shanghai, China) for 1h at room temperature. After incubation for 1h at room temperature, Actin-Tracker Red-555 (Beyotime Co., Shanghai, China) was added for 1 h. Finally, DAPI (Beyotime, Shanghai, China) was added to stain the nuclei. Macrophage polarization assay Raw 246.7 cells were wall-plated and 10 ng/mL of LPS was added to induce macrophage M1 polarization. dECMMA, dECMMAZn, dECMMACu, and dECMMAZn/Cu were added for treatment, and immunofluorescence detection or flow assay was performed after 12 h of co-culture. HUVECs vascularization experiment To observe the effect of materials on cell morphology and connectivity structure during the vascularization of HUVECs, 6-well confocal culture dishes were pre-laid with Matrigel (200 μL/well) and placed in 37 °C for 30 min of incubation for gelation. Subsequently, HUVECs were inoculated on the surface of Matrigel at a density of 2 × 105 cells/well, and the culture medium of different treatment groups was added, and the plates were incubated at 37 °C and 5% CO2 for 6 h. After incubation, the plates were washed gently with PBS, fixed in 4% paraformaldehyde for 15 min, permeabilized, closed, and then subjected to immunofluorescence staining for confocal laser microscopy to observe the vascular-like structure, cellular connection and skeleton remodeling and other indexes [48]. Bulk RNA sequencing Total RNA was isolated using the RNeasy Kit (Vazyme Co., Nanjing, China) following the manufacturer's protocol. RNA quality was verified with an Agilent 4200 TapeStation (G2991A, Agilent, Santa Clara, CA) and quantified using a Qubit 3.0 Fluorometer (Cat#Q33216, Thermo Fisher Scientific, Waltham, MA)/NanoDrop One (Thermo Fisher Scientific, Waltham, MA). High-quality RNA was used to construct sequencing libraries with the VAHTS Stranded mRNA-seq Library Prep Kit (NR602, Vazyme Co., Nanjing, China). Library concentration and integrity were assessed using the Qubit system and TapeStation. Sequencing was performed on the Illumina platform using paired-end 150 bp reads (PE150). Illumina sequencing by synthesis (SBS) technology incorporates fluorescently labeled nucleotides during cluster amplification, with emission signals captured and translated into base calls. Data processing and statistical analyses were performed on a Linux-based computational platform using R software for transcriptomic analysis and visualization. Animal ethics license All animal husbandry and experiments were approved by the Animal Ethics Committee of Shanghai Songjiang District Chedun Experimental Animal Breeding Farm Co., Ltd (AD2022056) and strictly followed the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. AGA model The AGA model was established by subcutaneous injection of testosterone solution on the back of C57BL/6 mice (n = 3). During the experimental period (28 days), each animal was injected daily with 0.1 mL of 5 mg/mL testosterone solution. 2 × 3 cm2 of hair on the dorsal skin was scraped off on the 14th day after injection. Mice were randomized into groups. The skin of each animal was photographed every 2 days. Another healthy mouse without testosterone injection was used as a positive control group. At the end of the experiment, the area covered by new hairs in the treated skin was measured and the skin of each animal was collected for subsequent studies [49]. H&E staining and immunohistochemistry Tissue samples were fixed in 4% paraformaldehyde at 4 °C for 24 h, dehydrated in graded ethanol, embedded in paraffin, and sectioned at 4 μm (skin). Bone samples were decalcified in 10% EDTA solution (pH 7.4) at 4 °C for 21 days with solution changes every two days prior to embedding. Histopathological features were evaluated by H&E staining. For immunohistochemistry, sections were deparaffinized, rehydrated, and subjected to heat-induced epitope retrieval in sodium citrate buffer (pH 6.0) at 95 °C for 15 min, followed by blocking with goat serum. Sections were then incubated overnight with primary antibodies and subsequently with biotinylated secondary antibodies. H&E and IHC staining were performed using standard protocols. Quantification was conducted with ImageJ software: positive staining area or integrated optical density (IOD) was measured from at least five randomly selected fields per sample. Masson's trichrome staining of skin sections Dorsal skin tissues were harvested, fixed in 4% paraformaldehyde at 4 °C for 24 h, dehydrated through a graded ethanol series, cleared in xylene, and embedded in paraffin. Sections (4 μm) were cut using a microtome and mounted on glass slides. After deparaffinization and rehydration, the sections were mordanted in Bouin's solution at 56 °C for 1 h to enhance staining contrast, followed by washing in running tap water until the yellow color disappeared. Nuclear staining was performed using Weigert's iron hematoxylin for 10 min, followed by rinsing with distilled water. Cytoplasmic and muscle components were stained with Biebrich scarlet-acid fuchsin solution for 10 min, then differentiated with phosphomolybdic-phosphotungstic acid solution for 10 min. Collagen fibers were stained with aniline blue for 5 min, followed by a brief rinse with 1% acetic acid. Finally, sections were dehydrated through graded ethanol, cleared in xylene, and mounted with neutral resin. The collagen fibers appeared blue, cytoplasm and muscle red, and nuclei dark brown or black. Stained slides were imaged using a light microscope (3DHISTECH, Hungary). Data analysis Data are presented as mean ± standard deviation (SD). A two-sided Student's t-test was used to compare differences between the two groups. For comparisons among multiple groups, one-way analysis of variance (ANOVA) followed by Tukey's multiple comparisons test was performed. Statistical significance was set at P< 0.05. All statistical analyses were conducted using GraphPad Prism software. ∗ indicates P< 0.05, ∗∗ indicates P< 0.01, ∗∗∗ indicates P < 0.001, and ns indicates not significant. Results Impact of metalloproteases activity on aging of hair follicle stem cell niche The follicular enzymatic reservoir is a key system for regulating hair follicle stem cell activity and ECM homeostasis, with its core components comprising various metal ion-dependent metalloproteases [50,51]. These enzymes typically exist as inactive zymogens and require conformational rearrangement induced by metal ions such as Zn2+ and Cu2+ to become active. Once activated, they mediate the degradation and remodeling of the ECM. In this work, we first used bioinformatics analysis (NCBI Gene Expression Omnibus (GEO). Dataset: GSE184501, n = 3.) to explore the relationship between Zn2+/Cu2+-dependent metalloproteases and ECM homeostasis during hair follicle niche aging. Volcanogram analysis (Fig. 1A) revealed that a large number of genes were significantly down- or up-regulated in the alopecia group. Further analysis revealed that the alopecia-associated senescence marker gene CDKN2A was significantly up-regulated in the alopecia group (Fig. 1B), validating the senescence signature of the alopecia samples. In the analysis of metal ion-related protease expression, we found that both the zinc ion-dependent MMPs family and the copper ion-dependent LOX family were significantly reduced in alopecia areata samples. Specifically, heat map analysis (Fig. 1D) showed that the expression of zinc-dependent proteases MMP-2, MMP-9, MMP-24, MMP-19, MMP-10, and MMP-14 was significantly down-regulated in the alopecia areata group, suggesting that zinc-ion-dependent remodeling of the ECM was significantly diminished, reduced expression of zinc finger protein families (ZFPs) indicates reduced zinc transport capacity (Fig. 1F) Meanwhile, the copper ion-dependent lysyl oxidase family (LOX, LOXL2, LOXL3) expression was also significantly reduced in the alopecia areata group (Fig. 1E). Quantitative analysis (Fig. 1C) further confirmed the significant decrease of LOX, LOXL2, and LOXL3. In addition, the superoxide dismutase family (SODs), which are key enzymes for oxidative stress, especially Sod1, Sod2, and Sod3, were also significantly down-regulated in the alopecia group. We identified cellular extracellular matrix orgnization (Fig. 1G), collagen-containing extracellular matrix (Fig. 1H), collagen binding (Fig. 1I) by GO analysis of 3425 genes with significantly decreased expression), extracellular matrix binding (Fig. 1I), and other extracellular matrix-associated biological processes with reduced biological activity. KEGG analysis revealed reduced activity of ECM-receptor interaction biological processes (Fig. 1J). Notably, calcium-related pathways were also altered in the transcriptomic analysis. However, Ca2+ primarily functions as a signaling mediator, whereas Zn2+ and Cu2+ directly regulate metalloprotease activity through coordination-dependent catalytic mechanisms.Fig. 1Transcriptome analysis and functional enrichment analysis of differentially expressed genes in hair follicle tissues of balding and non-balding hair follicles. (A) Volcano plot analysis of differentially expressed genes (blue: significantly down-regulated; red: significantly up-regulated); (B) Comparison of the expression levels of CDKN2A, a senescence marker gene, in the pemphigus group and the non-pemphigus group; (C) Quantitative comparison of the expression levels of copper ion-dependent lysyl oxidase family (LOX, LOXL2, LOXL3) and superoxide dismutase family (SOD1, SOD2, SOD3) genes; (D-F) Heatmap analysis of the expression of zinc ion-dependent matrix metalloproteinase families (MMPs), copper ion-dependent lysyl oxidase families (LOX) and superoxide dismutase families (SODs) as well as zinc finger protein families (ZFPs); (G-I) GO functional enrichment analysis of significantly down-regulated genes showing major enrichment entries for biological processes, cellular components and molecular functions, respectively; (J) KEGG pathway enrichment analysis of significantly down-regulated genes. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. Transcriptome analysis and functional enrichment analysis of differentially expressed genes in hair follicle tissues of balding and non-balding hair follicles. (A) Volcano plot analysis of differentially expressed genes (blue: significantly down-regulated; red: significantly up-regulated); (B) Comparison of the expression levels of CDKN2A, a senescence marker gene, in the pemphigus group and the non-pemphigus group; (C) Quantitative comparison of the expression levels of copper ion-dependent lysyl oxidase family (LOX, LOXL2, LOXL3) and superoxide dismutase family (SOD1, SOD2, SOD3) genes; (D-F) Heatmap analysis of the expression of zinc ion-dependent matrix metalloproteinase families (MMPs), copper ion-dependent lysyl oxidase families (LOX) and superoxide dismutase families (SODs) as well as zinc finger protein families (ZFPs); (G-I) GO functional enrichment analysis of significantly down-regulated genes showing major enrichment entries for biological processes, cellular components and molecular functions, respectively; (J) KEGG pathway enrichment analysis of significantly down-regulated genes. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. In summary, the significant decrease in the expression of zinc and copper ion-dependent metalloprotease family revealed the molecular basis of the impaired function of follicular enzyme nutrient pools and the imbalance of ECM homeostasis during alopecia, which may be an important mechanism for the development of follicular aging and degenerative alopecia. Activation of protease activity by metal ion-mediated conformational regulation In a follow-up study, to facilitate the study of the roles of Cu2+/Zn2+-dependent proteases in the enzyme nutrient pool of the hair follicle, we selected the Cu2+-dependent protease LOX and the Cu2+/Zn2+-dependent protease SOD1. Previous studies have shown that LOX is involved in regulating hair follicle structure and the hair growth cycle, primarily by promoting ECM cross-linking, maintaining mechanical stability, activating hair follicle stem cells, and modulating regenerative signaling pathways. In contrast, SOD1 protects stem cell function by scavenging ROS and maintaining redox homeostasis. To evaluated the binding properties and conformational stability of LOX and SOD1 proteins with metal ions (Cu2+ and Zn2+), molecular dynamics (MD) simulations were performed. The original model of LOX protein (Fig. 2A) and its binding model with Cu2+ (Fig. 2B), and the original model of SOD1 protein (Fig. 2D) and its binding model with Cu2+/Zn2+ (Fig. 2E) were constructed, respectively. The Cu2+ in the LOX protein mainly formed obvious ligand interactions with His297, while the Cu2+/Zn2+ in the SOD1 protein interacted with His46, His48, His63, His71, His120 and Asp84, respectively, and several amino acid residues. The kinetic simulation results showed that the RMSD value of the LOX-copper binding model (Fig. 2C) rapidly stabilized in the range of about 0.2∼0.3 nm within 100 ns, while the RMSD value of the SOD1- Cu2+/Zn2+ binding model (Fig. 2F) was more stable in the early stage of the simulation, and then fluctuated to a certain extent after about 70 ns, but still remained below 0.3 nm, indicating improved structural stability upon metal binding. Furthermore, extended MD analyses revealed multi-level stabilization effects induced by Zn2+/Cu2+ coordination. RMSD analysis (Fig. 2G and I) showed reduced structural fluctuations in metal-bound forms compared with apo proteins, while RMSF results (Fig. 2H and J) indicated decreased residue flexibility, particularly in catalytically relevant regions. DCCM analysis (Fig. 2K and L) further demonstrated strengthened residue interaction networks, with increased correlation strength and expanded strongly coupled residue pairs in both LOX and SOD1. In addition, MM-PBSA calculations yielded favorable binding free energies (−11.99 kcal/mol for LOX and −21.72 kcal/mol for SOD1), confirming thermodynamically stable metal coordination.Fig. 2Molecular dynamics simulation of LOX and SOD1 proteins with zinc or copper. (A) Original structural model of LOX protein; (B) Copper-binding model of LOX highlighting the interaction between copper ion and residue His297; (C) RMSD analysis of copper-binding LOX model indicating stability within 100 ns simulation; (D) Original structural model of SOD1 protein; (E) Structural model of SOD1 protein bound with copper and zinc ions, showing interactions with residues His46, His48, His63, His71, His120, and Asp84; (F) RMSD profile of zinc/copper-binding SOD1 model within 100 ns simulation timeframe; (G) RMSD comparison of LOX in apo and copper-bound states over the simulation time, showing reduced structural fluctuations upon metal coordination. (H) RMSF analysis of LOX, indicating decreased residue-level flexibility in the copper-bound form, particularly in functionally relevant regions. (I) RMSD comparison of SOD1 in apo and copper/zinc-bound states, demonstrating enhanced structural stability after metal binding. (J) RMSF analysis of SOD1, showing reduced residue fluctuations in the metal-bound system. (K, L) ΔDCCM maps (holo-apo) of LOX and SOD1 showing changes in residue correlation upon metal ion coordination. Positive correlations (green) and negative correlations (magenta) indicate enhanced or reduced coupled motions, respectively. Molecular dynamics simulation of LOX and SOD1 proteins with zinc or copper. (A) Original structural model of LOX protein; (B) Copper-binding model of LOX highlighting the interaction between copper ion and residue His297; (C) RMSD analysis of copper-binding LOX model indicating stability within 100 ns simulation; (D) Original structural model of SOD1 protein; (E) Structural model of SOD1 protein bound with copper and zinc ions, showing interactions with residues His46, His48, His63, His71, His120, and Asp84; (F) RMSD profile of zinc/copper-binding SOD1 model within 100 ns simulation timeframe; (G) RMSD comparison of LOX in apo and copper-bound states over the simulation time, showing reduced structural fluctuations upon metal coordination. (H) RMSF analysis of LOX, indicating decreased residue-level flexibility in the copper-bound form, particularly in functionally relevant regions. (I) RMSD comparison of SOD1 in apo and copper/zinc-bound states, demonstrating enhanced structural stability after metal binding. (J) RMSF analysis of SOD1, showing reduced residue fluctuations in the metal-bound system. (K, L) ΔDCCM maps (holo-apo) of LOX and SOD1 showing changes in residue correlation upon metal ion coordination. Positive correlations (green) and negative correlations (magenta) indicate enhanced or reduced coupled motions, respectively. Importantly, these structural and dynamic changes provide a mechanistic basis linking metal coordination to enzymatic activation. The coordination between Cu2+ and His297 in LOX is likely to stabilize its catalytic domain, thereby facilitating ECM cross-linking activity, while the stabilized Cu2+/Zn2+ binding environment in SOD1 supports efficient ROS scavenging. Together, these findings suggest that Zn2+/Cu2+ regulate enzymatic function primarily through conformation stabilization rather than expression modulation, thereby establishing a structural-functional framework for microenvironmental restoration. Preparation and characterization of dECMMAZn/Cu microneedles Conventional drug delivery to hair follicles has been plagued with problems such as uneven drug distribution, insufficient penetration depth and obvious skin trauma. In order to effectively promote drug delivery, a dECMMAZn/Cu microneedle system was constructed in this study to achieve precise regulation of the local microenvironment of the hair follicle. The microneedle system can effectively penetrate the skin stratum corneum and release Zn2+ and Cu2+ into the microenvironment of the hair follicle cell niche in a sustained and stable manner to precisely activate Zn2+ and Cu2+-dependent proteases, thus realizing the long-lasting modulation of the activity of hair follicle ECM and stem cells. First, dECMMA was prepared as a 5% hydrogel. Subsequently, either Zn2+ and Cu2+ were added to the dECMMA hydrogel to generate dECMMAZn/Cu hydrogels. And then, we observed the surface morphology of the dECMMA hydrogels using scanning electron microscopy (SEM) and environmental scanning electron microscopy (ESEM). The results showed that all the samples showed porous structure on the surface. Meanwhile, through energy spectrum analysis and semi-quantitative detection, we found that the elements C and N elements were present in all hydrogels. In addition, the presentation of Zn2+ and Cu2+ in dECMMA was detected as well (Fig. 3A). As the dECMMA hydrogel gradually degraded, Zn2+ and Cu2+ were slowly released, ensuring continuous bioactivity throughout the therapeutic process and maximizing the effective utilization of the ions (Fig. 3B). Semi-quantitative statistical analysis revealed that the elemental densities of Zn2+ and Cu2+ in the dECMMAZn/Cu were lower than the respective elemental densities observed in the dECMMAZn and dECMMACu (Fig. 3C).Fig. 3Physicochemical characterization of dECMMA hydrogel and microneedle patch system. (A) SEM images and elemental distribution maps demonstrating the surface morphology and elemental (carbon, oxygen, zinc, copper) distribution (scale = 5 μm) of different groups; (B, C) In vitro release behavior of Zn2+ and Cu2+ from dECMMAZn/Cn (ICP detection), data expressed as Mean ± SD (n = 3); (D, E) FTIR and XRD mapping analysis; (F) thermogravimetric analysis curves of dECMMA hydrogels; (G) XPS elemental analysis of dECMMA hydrogels; (H) Schematic diagrams of the dECMMAZn/Cn microneedle preparation process; (I) SEM images and (K) EDS analysis of the microneedle structure of dECMMAZn/Cn microneedle patch; (J) Macroscopic images of different dECMMA microneedle systems. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. Physicochemical characterization of dECMMA hydrogel and microneedle patch system. (A) SEM images and elemental distribution maps demonstrating the surface morphology and elemental (carbon, oxygen, zinc, copper) distribution (scale = 5 μm) of different groups; (B, C) In vitro release behavior of Zn2+ and Cu2+ from dECMMAZn/Cn (ICP detection), data expressed as Mean ± SD (n = 3); (D, E) FTIR and XRD mapping analysis; (F) thermogravimetric analysis curves of dECMMA hydrogels; (G) XPS elemental analysis of dECMMA hydrogels; (H) Schematic diagrams of the dECMMAZn/Cn microneedle preparation process; (I) SEM images and (K) EDS analysis of the microneedle structure of dECMMAZn/Cn microneedle patch; (J) Macroscopic images of different dECMMA microneedle systems. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. Additionally, Fourier transform infrared spectroscopy (FTIR) analysis revealed characteristic absorption peaks of F127 at 2895 cm−1 (C-H stretching), 1347 cm−1 (C-H bending), 1466 cm−1 (C-C stretching), and 1105 cm−1 (C-O stretching). FTIR analysis also identified a collodionic amide B-band absorption peak, which is associated with C-N stretching and CH2 stretching vibrations. Furthermore, the characteristic amide III band absorption peaks observed at 1270 cm−1 and 1281 cm−1 in the corresponding collagen were attributed to C-N stretching and N-H bending vibrations, respectively (Fig. 3D). The presence of these characteristic peaks indicates the composition and role in dECMMA hydrogel. In the XRD patterns, the dECMMA hydrogels showed two major diffraction peaks of collagen at 2θ = 19.16° and 23.38°, and the diffraction intensities of all the samples were close to zero in the region of the high 2θ angle, which suggests that there is no significant crystalline structure at these angles (Fig. 3E). This implies that both Zn2+ and Cu2+ are present in dECMMA. To evaluate the thermal stability of these scaffolds, we employed thermogravimetric analysis (TGA). TGA data demonstrated the weight loss of dECMMA with increasing temperature, revealing that the incorporation of inorganic ions enhances the thermal stability of dECMMA (Fig. 3F). In the XPS survey spectrum, distinct peaks for Zn and Cu were observed, indicating their effective incorporation (Fig. 3G). After establishing the preparation process for dECMMAZn/Cu hydrogel materials and the incorporation of metal ions, we further fabricated microneedle patches using a pre-made mold (Fig. 3H). We examined the different microneedle patches using SEM and EDS, and found that the tips of the microneedles exhibited a porous structure and contained Zn and Cu elements (Fig. 3I and K). In macroscopic images, the dECMMAZn/Cu microneedle patch also exhibited a highly regular structure and demonstrated decent hardness (Fig. 3J). H&E staining revealed clear microchannels penetrating the stratum corneum into the epidermis, confirming effective insertion of the microneedles into skin tissue (Fig. S2). The dECMMA microneedles exhibited time-dependent swelling, with gradual structural deformation observed at 8-16 h and near-complete loss of tip integrity by 24 h (Fig. S3), indicating rapid in situ degradation. The force-displacement curves show a continuous increase in force without abrupt failure, indicating good mechanical strength and structural integrity of the microneedles (Fig. S4). The above results indicate that the dECMMAZn/Cu microneedle patches were successfully prepared. In vitro evaluation of the safety and migration of dECMMAZn/Cu microneedle patches We first evaluated the in vitro proliferation, migration, and invasion abilities related to the dECMMAZn/Cu microneedle patches. In this study, classical dermal papilla stem cells (DPSCs) from the hair follicle niche were used and the microneedle patch extract in the culture medium was collected for cell incubation. First, DPSCs were isolated from the dorsal skin of mice (Fig. 4A). The experiment was divided into four groups, dECMMA, dECMMAZn, dECMMACu and dECMMAZn/Cu groups. Live/dead staining analysis after 1, 4, and 7 days of co-culture showed no significant differences in cell death among groups (Fig. 4B). Cell proliferation at different time points was assessed using the CCK8 assay. After 7 days of co-culture, cell proliferation in the dECMMAZn, dECMMACu, and dECMMAZn/Cu groups was significantly enhanced compared to the dECMMA group (Fig. 4C). To further evaluate the cell migration after dECMMAZn/Cu microneedle patch extract treatments, a scratch assay was performed in vitro. After 12 h of treatment, the wound healing ability of cells in the ion-doped groups was significantly improved compared to the dECMMA group (Fig. 4D and E). Furthermore, data of Transwell assays demonstrated that after 24 h of dECMMAZn/Cu microneedle patch extract co-incubation, DPSC migration was significantly enhanced (Fig. 4F and G).Fig. 4In vitro cytotoxicity analysis of dECMMAZn/Cu microneedle patch. (A) Schematic diagram of dermal papilla stem cell (DPSC) isolation and culture (Created with BioRender.com, with permission); (B) Live/dead staining of DPSCs (green: live cells; red: dead cells); (C) Cell proliferation analysis by CCK-8 assay; (D) Scratch wound healing assay data (scale bar = 100 μm); (E) Quantification of wound closure area in scratch assay; (F) Transwell migration assay for cell migration (Created with BioRender.com, with permission); (G) Quantification of transwell migration assay. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. In vitro cytotoxicity analysis of dECMMAZn/Cu microneedle patch. (A) Schematic diagram of dermal papilla stem cell (DPSC) isolation and culture (Created with BioRender.com, with permission); (B) Live/dead staining of DPSCs (green: live cells; red: dead cells); (C) Cell proliferation analysis by CCK-8 assay; (D) Scratch wound healing assay data (scale bar = 100 μm); (E) Quantification of wound closure area in scratch assay; (F) Transwell migration assay for cell migration (Created with BioRender.com, with permission); (G) Quantification of transwell migration assay. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. These results indicate that dECMMAZn/Cu microneedle patch exhibit low cytotoxicity, and the Zn2+ and Cu2+ doping may promote the migration and proliferation abilities of DPSCs. dECMMAZn/Cu microneedle patches enhanced the migration and angiogenic potential of HUVECs in vitro During the pathological progression of degenerative alopecia, insufficient vascularization in the perifollicular microenvironment is one of the key driving factors. DHT-induced oxidative stress and inflammatory responses may further impair the function of HUVECs, suppressing their proliferation and migration. To evaluate the effect of dECMMAZn/Cu microneedle patches on HUVECs, we compared dECMMA, dECMMAZn, dECMMACu and dECMMAZn/Cu in terms of HUVEC proliferation, migration, invasion, and angiogenic performance. Live/Dead staining and CCK-8 assays showed that dECMMAZn/Cu markedly promoted cell proliferation compared with other groups, indicating that Zn2+/Cu2+ synergy significantly enhances endothelial metabolic activity and growth (Fig. 5A and D). Scratch assays (Fig. 5 B and E) demonstrated accelerated wound closure in the dECMMAZn/Cu group within 12 h, while Transwell assays (Fig. 5C and F) confirmed a substantial increase in both migration rate and the number of invasive cells. ELISA quantification (Fig. 5G) revealed that VEGF secretion was significantly elevated in the dECMMAZn/Cu group (approximately 1380 pg/mL) compared with the other groups, suggesting that dECMMAZn/Cu activates proangiogenic signaling and paracrine secretion. Tube formation assays (Fig. 5H) showed that HUVECs cultured on dECMMAZn/Cu formed denser, more continuous, and well-branched capillary-like networks. Quantitative analyses (Fig. 5I–L) indicated that the numbers of meshes, nodes, junctions, and branches were all significantly higher in the dECMMAZn/Cu group, confirming enhanced angiogenic potential.Fig. 5Effects of d dECMMAZn/Cu microneedle patch on HUVEC activity and angiogenesis. (A) Live/Dead staining of HUVECs cultured on dECMMA, dECMMAZn, dECMMACu, and dECMMAZn/Cu for 1, 4, and 7 days (green: live cells; red: dead cells); (B) Representative scratch wound images at 0 h and 12 h showing migration ability (scale bar = 100 μm). (C) Transwell migration assay for cell migration; (D) Cell proliferation analysis by CCK-8 assay; (E) Quantification of relative migration rates; (F) Number of invasive cells; (G) VEGF secretion levels determined by ELISA; (H) Fluorescence images of tube formation stained for F-actin (red) and DAPI (blue); (I-L) Quantification of the number of meshes, nodes, junctions, and branches formed in vitro. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. Effects of d dECMMAZn/Cu microneedle patch on HUVEC activity and angiogenesis. (A) Live/Dead staining of HUVECs cultured on dECMMA, dECMMAZn, dECMMACu, and dECMMAZn/Cu for 1, 4, and 7 days (green: live cells; red: dead cells); (B) Representative scratch wound images at 0 h and 12 h showing migration ability (scale bar = 100 μm). (C) Transwell migration assay for cell migration; (D) Cell proliferation analysis by CCK-8 assay; (E) Quantification of relative migration rates; (F) Number of invasive cells; (G) VEGF secretion levels determined by ELISA; (H) Fluorescence images of tube formation stained for F-actin (red) and DAPI (blue); (I-L) Quantification of the number of meshes, nodes, junctions, and branches formed in vitro. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. Taken together, these results demonstrate that dECMMAZn/Cu significantly promotes HUVEC proliferation, migration, invasion, and tube formation. The synergistic interaction between Zn2+ and Cu2+ likely modulates cytoskeletal remodeling, upregulates VEGF secretion, and activates endothelial angiogenic pathways, thereby reconstructing a proangiogenic microenvironment. dECMMAZn/Cu microneedle patches regulate the macrophage polarization to promote immune homeostasis reconstruction in vitro Given the intimate coupling between angiogenesis and immune regulation, we further explored whether the dECMMAZn/Cu scaffold could modulate macrophage polarization to establish immune homeostasis. RAW264.7 macrophages were primed with LPS for 6 h to induce an M1 phenotype, then co-cultured with dECMMA, dECMMAZn, dECMMACu, or dECMMAZn/Cu scaffolds for 24 h to assess immunomodulation (Fig. 6A). The polarization status was then analyzed by immunofluorescence staining and flow cytometry. LPS stimulation markedly increased iNOS (green) expression in the Blank and dECMMA groups, indicating a dominant M1 phenotype. In contrast, macrophages cultured with dECMMAZn/Cu exhibited reduced iNOS expression and enhanced CD206 (red) expression, indicating a shift toward the M2 reparative phenotype (Fig. 6B and E). Flow cytometry showed that LPS stimulation upregulated CD86 (M1 marker) expression, whereas co-culture with dECMMAZn/Cu suppressed CD86 fluorescence intensity while significantly increasing CD206 expression (Fig. 6C and D). Correspondingly, the mean fluorescence intensity (MFI) of CD206 was markedly elevated, while that of CD86 decreased significantly (Fig. 6F and G).Fig. 6Macrophage polarization assay. (A) Schematic diagram of macrophage polarization assay detection (Created with BioRender.com, with permission); (B) Immunofluorescence detection of macrophage iNOS (green, M1 marker) and CD206 (red, M2 marker) expression (scale bar = 50 μm); (C, D) Flow cytometric analysis of CD86 (M1 marker) and CD206 (M2 marker) fluorescence intensity distributions; (E) Quantification of iNOS+ and CD206+ cell proportions among total cells. (F, G) Quantitative analysis of mean fluorescence intensity (MFI) for CD206 and CD86. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. Macrophage polarization assay. (A) Schematic diagram of macrophage polarization assay detection (Created with BioRender.com, with permission); (B) Immunofluorescence detection of macrophage iNOS (green, M1 marker) and CD206 (red, M2 marker) expression (scale bar = 50 μm); (C, D) Flow cytometric analysis of CD86 (M1 marker) and CD206 (M2 marker) fluorescence intensity distributions; (E) Quantification of iNOS+ and CD206+ cell proportions among total cells. (F, G) Quantitative analysis of mean fluorescence intensity (MFI) for CD206 and CD86. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. These results demonstrate that dECMMAZn/Cu not only enhances endothelial angiogenesis but also reprograms macrophage polarization, promoting a transition from the proinflammatory M1 phenotype toward the anti-inflammatory and tissue-repairing M2 phenotype. The synergistic action of Zn2+ and Cu2+ likely modulates macrophage redox balance and signaling pathways, leading to an immunoregulatory microenvironment conducive to vascular regeneration and tissue healing. dECMMAZn/Cu alleviates DHT-induced senescence of DPSCs by reducing oxidative stress and inflammatory signaling in vitro During the pathological progression of degenerative alopecia, the aging of DPSCs is recognized as a critical mechanism driving follicular miniaturization and hair loss. Dihydrotestosterone (DHT)-induced oxidative stress promotes the accumulation of ROS, leading to DNA and mitochondrial damage in DPSCs and consequently accelerating cellular senescence. Given our earlier findings that dECMMAZn/Cu promotes angiogenesis and re-establishes immune homeostasis, we further investigated whether this biomimetic matrix could counteract DHT-induced oxidative injury and aging in the hair follicle niche (Fig. 7A). Exposure of DPCs to DHT led to a concentration-dependent upregulation of senescence-associated genes p16, p21, and p27 (Fig. 7B), confirming successful induction of cellular senescence. DHT stimulation also elevated the expression of proinflammatory cytokines IL-1β and IL-6 (Fig. 7D), reflecting the onset of a senescence-associated secretory phenotype (SASP). Microscopic and ROS fluorescence analyses (Fig. 7C and E) revealed that DPSCs cultured on dECMMAZn/Cu exhibited preserved spindle morphology, lower ROS accumulation, and enhanced cellular density compared with those cultured on dECMMA or single-ion-doped matrices. LOX activity was significantly enhanced in the dECMMAZn/Cu group, supporting ion-mediated restoration of enzymatic function (Fig. S5). CCK-8 assays (Fig. 7F) confirmed that all scaffolds supported comparable proliferation, excluding cytotoxic effects from metal ion incorporation. qRT-PCR analysis (Fig. 7G) further demonstrated that dECMMAZn/Cu significantly downregulated p16 and p21 expression while upregulating Spp1, a marker associated with ECM remodeling and cellular rejuvenation.Fig. 7dECMMAZn/Cu alleviates DHT-induced senescence in DPSCs. (A) Schematic diagram illustrating DHT-induced DPC aging and rejuvenation mechanisms through the p16/p21 pathway (Created with BioRender.com, with permission); (B) Relative expression of senescence markers p16, p21, and p27 after treatment with 10 nM or 500 nM DHT; (C) Microscopy and ROS fluorescence images of DPCs cultured on different dECM scaffolds under DHT stimulation for 1, 4, and 7 days. Scale bar = 100 μm; (D) Expression of inflammatory cytokines IL-1β and IL-6 after DHT exposure; (E) Quantification of ROS+ cells across different scaffold groups; (F) CCK-8 assay showing cell viability under DHT treatment; (G) Relative expression of p16, p21, and Spp1 in DPSCs co-cultured with dECMMAZn/Cu under DHT stimulation. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. dECMMAZn/Cu alleviates DHT-induced senescence in DPSCs. (A) Schematic diagram illustrating DHT-induced DPC aging and rejuvenation mechanisms through the p16/p21 pathway (Created with BioRender.com, with permission); (B) Relative expression of senescence markers p16, p21, and p27 after treatment with 10 nM or 500 nM DHT; (C) Microscopy and ROS fluorescence images of DPCs cultured on different dECM scaffolds under DHT stimulation for 1, 4, and 7 days. Scale bar = 100 μm; (D) Expression of inflammatory cytokines IL-1β and IL-6 after DHT exposure; (E) Quantification of ROS+ cells across different scaffold groups; (F) CCK-8 assay showing cell viability under DHT treatment; (G) Relative expression of p16, p21, and Spp1 in DPSCs co-cultured with dECMMAZn/Cu under DHT stimulation. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. Collectively, these results demonstrate that dECMMAZn/Cu effectively mitigates DHT-induced oxidative stress and inflammation in DPSCs, attenuating senescence marker expression and promoting a regenerative phenotype. In conjunction with its previously demonstrated angiogenic and immunomodulatory functions, this multifunctional dual-metal scaffold establishes a favorable microenvironment for reversing hair follicle niche aging and restoring regenerative capacity. dECMMAZn/Cu delays the senescence of DPSCs by inhibiting p16 and p21 in vitro Building on the above findings that dECMMAZn/Cu protects DPSCs from DHT-induced oxidative stress and premature senescence, we next sought to determine whether this protective effect extends to intrinsic, replication-driven aging. Unlike DHT-induced stress, which mimics extrinsic hormonal and oxidative insults, long-term serial passaging of DPSCs models spontaneous replicative senescence accompanied by DNA damage accumulation and p16/p21 pathway activation. Therefore, this model enables further verification of the intrinsic anti-aging capacity of the dual-ion scaffold. DPSCs were isolated from mouse dorsal skin and cultured on dECMMA, dECMMAZn, dECMMACu, and dECMMAZn/Cu scaffolds for five consecutive passages. SA-β-gal staining revealed a pronounced accumulation of senescent cells in the dECMMA group, whereas Zn2+ or Cu2+ doping each reduce the percentage of SA-β-gal positive cell numbers, with dECMMAZn/Cu exhibiting the most significant decline (Fig. 8A and B). Immunofluorescence staining revealed that the proportions of p16 positive cells (Fig. 8C and D) and γ-H2AX positive cells-a marker of DNA double-strand breaks (Fig. 8E and F)-were both markedly reduced in the dECMMAZn/Cu group. Serial-passage assays indicated that DPSCs grown on dECMMAZn/Cu maintained a higher cumulative population-doubling number than those on the other scaffolds (Fig. 8G), reflecting delayed replicative senescence. qRT-PCR further showed significant downregulation of p16 and p21 mRNA levels (Fig. 8H), and Western blot analysis confirmed reduced p16 protein expression (Fig. 8I). To exclude potential interference from residual photoinitiator (LAP) and to evaluate the contribution of individual components, the expression of senescence markers was analyzed. As shown in Fig. S7, no significant differences were observed between the Blank and LAP groups, indicating negligible effects of LAP. In contrast, the Zn/Cu group moderately reduced p16 and p21 expression, while the dECMMAZn/Cu group significantly downregulated both markers, suggesting a synergistic anti-senescence effect.Fig. 8dECMMAZn/Cu reverses aging phenotypes and DNA damage in DPSCs. (A) SA-β-gal staining of DPSCs cultured on different dECM scaffolds, showing reduced senescence in the dECMMAZn/Cu group. Scale bar = 100 μm; (B) Western blot analysis of p16 protein expression normalized to GAPDH; (C) Immunofluorescence images showing p16 (green), F-actin (red), and nuclei (blue, DAPI). Scale bars = 50 μm; (D) Quantification of SA-β-gal+ cell percentages; (E) Immunofluorescence staining of γ-H2AX (green) indicating DNA damage, with F-actin (red) and DAPI (blue). Scale bars = 50 μm; (F) qRT-PCR analysis of senescence markers p16 and p21; (G) Cell proliferation curves across multiple passages showing enhanced growth on dECMMAZn/Cu; (H, I) Quantitative analysis of p16+ and γ-H2AX+ cell percentages. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. dECMMAZn/Cu reverses aging phenotypes and DNA damage in DPSCs. (A) SA-β-gal staining of DPSCs cultured on different dECM scaffolds, showing reduced senescence in the dECMMAZn/Cu group. Scale bar = 100 μm; (B) Western blot analysis of p16 protein expression normalized to GAPDH; (C) Immunofluorescence images showing p16 (green), F-actin (red), and nuclei (blue, DAPI). Scale bars = 50 μm; (D) Quantification of SA-β-gal+ cell percentages; (E) Immunofluorescence staining of γ-H2AX (green) indicating DNA damage, with F-actin (red) and DAPI (blue). Scale bars = 50 μm; (F) qRT-PCR analysis of senescence markers p16 and p21; (G) Cell proliferation curves across multiple passages showing enhanced growth on dECMMAZn/Cu; (H, I) Quantitative analysis of p16+ and γ-H2AX+ cell percentages. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. Collectively, these findings demonstrate that Zn2+/Cu2+ co-doping mitigates DNA damage accumulation, suppresses p16/p21-mediated senescence signaling, and effectively delays DPSC aging. dECMMAZn/Cu effectively remodels the ECM to inhibit senescence of DPSCs in vitro To further explore the effects of the dECMMAZn/Cu on the transcriptional profiles of the cells, the differences in gene expression of the cells in different treatment groups were analyzed using RNA-seq technology. The volcano plot showed that a total of 127 significantly up-regulated genes and 181 significantly down-regulated genes were identified in the dECMMAZn/Cu-treated group compared with the normal dECMMA group (Fig. 9A). Heat map analysis further confirmed that the expression of antioxidant enzymes (e.g., Sod1, Sod2, Sod3) and Lox family genes (e.g., Loxl1, Loxl2, Loxl3, Loxl4), which are closely related to the remodeling of extracellular matrix, were significantly elevated in the dECMMAZn/Cu group (Fig. 9B). Meanwhile, the expression of metalloproteinase family members (e.g., Mmp8, Mmp10, Mmp16, Mmp19, Mmp24, Mmp27) was also significantly elevated in the dECMMAZn/Cu group (Fig. 9C).Fig. 9dECMMAZn/Cu effectively remodels the extracellular matrix to inhibit senescence of DPSCs. (A) Volcano plot analysis shows the number of significantly differentially expressed genes in dECMMAZn/Cu treatment compared with normal dECMMA treatment; (B) Heat map analysis of the expression levels of antioxidant enzymes and Lox family genes in the dECMMAZn/Cu treatment group; (C) Heat map analysis of the expression levels of metalloproteinase (Mmp) family members associated with extracellular matrix degradation in the dECMMAZn/Cu treatment group; (D) GO enrichment analysis of differentially expressed genes covering biological processe, cellular components and molecular functions, highlighting significantly enriched terms related to extracellular regions and extracellular matrix; (E) Heatmap analysis of zinc finger protein (Zfp) family gene expression levels in the dECMMAZn/Cu treatment group; (F-H) Heatmap analysis of the expression levels of differentially expressed genes belonging to the extracellular space (F), extracellular region (G), and extracellular matrix (H), respectively, in the dECMMAZn/Cu treatment group. dECMMAZn/Cu effectively remodels the extracellular matrix to inhibit senescence of DPSCs. (A) Volcano plot analysis shows the number of significantly differentially expressed genes in dECMMAZn/Cu treatment compared with normal dECMMA treatment; (B) Heat map analysis of the expression levels of antioxidant enzymes and Lox family genes in the dECMMAZn/Cu treatment group; (C) Heat map analysis of the expression levels of metalloproteinase (Mmp) family members associated with extracellular matrix degradation in the dECMMAZn/Cu treatment group; (D) GO enrichment analysis of differentially expressed genes covering biological processe, cellular components and molecular functions, highlighting significantly enriched terms related to extracellular regions and extracellular matrix; (E) Heatmap analysis of zinc finger protein (Zfp) family gene expression levels in the dECMMAZn/Cu treatment group; (F-H) Heatmap analysis of the expression levels of differentially expressed genes belonging to the extracellular space (F), extracellular region (G), and extracellular matrix (H), respectively, in the dECMMAZn/Cu treatment group. Gene ontology (GO) enrichment analysis showed that the 127 significantly upregulated genes were mainly enriched in biological processes such as extracellular region extracellular space and extracelluar matrix (Fig. 9D). In addition, gene expression profiling of the zinc finger protein family showed that most of the Zfp family members were significantly upregulated in the dECMMAZn/Cu group (Fig. 9E). Further analysis of differentially expressed genes related to extracellular space, extracellular region and extracellular matrix showed that Adamts20, Col26a1, Spp1, Eln and other key genes related to extracellular matrix stabilization and tissue remodeling were significantly up-regulated in the dECMMAZn/Cu group (Fig. 9E). Adamts20, Col26a1, Spp1, Eln and other key genes related to extracellular matrix stabilization and tissue remodeling were significantly up-regulated in the dECMMAZn/Cu treatment group (Fig. 9F–H). qPCR analysis further confirmed these findings (Fig. S6). While dECMMA moderately upregulated Spp1, Sod1, Lox, and Loxl1, the dECMMAZn/Cu group showed significantly higher expression, indicating enhanced activation of follicle-related pathways. In conclusion, dECMMAZn/Cu effectively optimized the cellular microenvironment and promoted the remodeling and stabilization of the extracellular matrix by regulating the expression profiles of key genes related to antioxidant, extracellular matrix remodeling and metal ions. dECMMAZn/Cu can promote hair regeneration in vivo To evaluate the promotional effect of different dECMMA systems on hair regeneration in a mouse model of androgenetic alopecia (AGA), a bimetallic ion-doped microneedle system was constructed and validated by in vivo experiments. Firstly, after daily subcutaneous injection of AGA solution (0.5 mg AGA/mouse) for a total of 14 days, the mice were depilated and microneedle administration was implemented on Day 0, and hair growth was observed and sampled on Day 6, 10 and 14 (Fig. 10A). It was found by photographic recording that the blank group (Blank) and the dECMMA group showed a significant decrease in hair coverage, while the dECMMAZn, dECMMACu and dECMMAZn/Cu groups showed stronger hair regeneration, especially the dECMMAZn/Cu group had the most complete hair coverage on Day 14, which demonstrated an obvious pro-regeneration effect (Fig. 10B). Quantitative results further confirmed that the dECMMAZn/Cu group achieved significantly higher hair coverage than the other treatment groups on Day 14 (P < 0.001) (Fig. 10C and D). As shown by Masson staining (Fig. 10E), the skin of the Sham group was structurally intact, with densely arranged collagen fibers in the dermis, and the hair follicles were abundant and in the growth stage. In the Blank/AGA group, the skin thickness was significantly reduced, large fat vacuoles appeared in the dermis, the collagen structure was loose, and the number of hair follicles was significantly reduced, showing a degenerative phase, reflecting a serious extracellular matrix disorder.Fig. 10dECMMAZn/Cu can promote hair regeneration in vivo. (A) Schematic of androgen-induced alopecia mouse model and treatment timeline (Created with BioRender.com, with permission); (B) Photomicrographs of mouse dorsal hair; (C) Statistics of hair growth on mouse dorsal back with 14 consecutive days of coverage; (D) Statistics of mouse dorsal back with 14th day of hair coverage; (E) Masson staining of mouse dorsal skin. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. dECMMAZn/Cu can promote hair regeneration in vivo. (A) Schematic of androgen-induced alopecia mouse model and treatment timeline (Created with BioRender.com, with permission); (B) Photomicrographs of mouse dorsal hair; (C) Statistics of hair growth on mouse dorsal back with 14 consecutive days of coverage; (D) Statistics of mouse dorsal back with 14th day of hair coverage; (E) Masson staining of mouse dorsal skin. Data are presented as mean ± SD (n = 3). Statistical analysis was performed using Student's t-test or one-way ANOVA followed by Tukey's multiple comparisons test where appropriate. ∗P< 0.05, ∗∗P< 0.01, ∗∗∗P < 0.001; ns, not significant. To further verify the molecular mechanism underlying ECM and enzymatic rejuvenation, immunofluorescence staining was performed to assess the in situ expression of SOD1 and LOX in regenerated skin tissues (Fig. S8). Compared with the Blank and dECMMA groups, both SOD1 (green) and LOX (red) signals were markedly enhanced in the dECMMAZn/Cu group, particularly surrounding hair follicles and dermal ECM regions, consistent with reactivation of Zn2+/Cu2+ dependent enzymatic networks. CD31 staining showed increased vascular density in the dECMMAZn/Cu-treated group, indicating enhanced angiogenesis (Fig. S9A). In parallel, γ-H2AX staining revealed reduced DNA damage and cellular senescence (Fig. S9B). These results further support the pro-regenerative effects of dECMMAZn/Cu in vivo. H&E staining of major organs (heart, liver, spleen, lung, and kidney) showed no obvious histopathological abnormalities in the dECMMAZn/Cu-treated group, indicating good in vivo biocompatibility and minimal systemic toxicity (Fig. S10). These results confirm that the dual-ion scaffold restores redox homeostasis and enzymatic cross-linking capacity within the follicular microenvironment. Collectively, these findings demonstrate that dECMMAZn/Cu microneedle treatment effectively reverses AGA-associated follicular degeneration by restoring ECM structural integrity, reactivating metalloprotease-dependent enzymatic activity, and promoting robust hair follicle regeneration in vivo. Discussion The core of hair follicle regeneration and aging lies in the imbalance of the “follicular enzymes”. This system regulates the homeostasis of the follicular stem cell microenvironment and provides essential metabolic support. Its decline leads to disrupted matrix crosslinking, redox imbalance, and weakened signal transduction. In this study, bioinformatics and molecular dynamics simulations revealed that several Zn2+/Cu2+-dependent metalloproteases (such as LOX and SOD1) were significantly downregulated in degenerative alopecia, exhibiting conformational instability and loss of catalytic activity. This enzymatic decline reduces the regenerative potential of the follicular microenvironment, indicating that metal ion homeostasis and enzyme conformational stability play a decisive role in follicular aging. Mechanistically, LOX-mediated collagen crosslinking governs ECM stiffness and structural integrity, whereas SOD1 maintains redox homeostasis to prevent ROS-induced matrix degradation. The coordinated decline of these enzymes disrupts the balance between matrix assembly and degradation, leading to impaired mechanotransduction and dysfunction of the follicular stem cell niche. To restore this system, we developed a Zn2+/Cu2+ dual-doped decellularized extracellular matrix microneedle (dECMMAZn/Cu), which reactivates the follicular enzymatic reservoir through ion-mediated protein conformational regulation. Unlike previous single-ion supplementation or topical drugs, this platform enables the synchronous delivery of ions and biomimetic matrix components, establishing a localized dynamic ionic microenvironment that restores enzyme conformational stability and catalytic activity at the molecular level. Material characterization confirmed that Zn2+ and Cu2+ form coordination crosslinks with functional groups in dECMMA, generating a thermally stable and mechanically enhanced network that ensures sustained ion release and bioactivity. Importantly, metal ion doping in this system is governed by coordination interactions between Zn2+/Cu2+ and functional groups within the dECMMA matrix. These reversible bonds regulate ion retention and release, maintaining a dynamic equilibrium between coordinated and free states, thereby enabling sustained and localized ion availability. This coordination-controlled reservoir underpins prolonged enzymatic activation and microenvironmental homeostasis. At the cellular level, dECMMAZn/Cu significantly promoted the proliferation and migration of DPSCs by reconstructing the local microenvironment and effectively downregulated senescence markers p16 and p21, suggesting rejuvenation of cellular senescence. Molecular dynamics simulations showed that coordination between Cu2+ and His297 in LOX stabilized the catalytic conformation, while the synergistic binding of Zn2+/Cu2+ in SOD1 maintained redox balance, providing a structural explanation for ion-mediated protein reactivation. Furthermore, dECMMAZn/Cu enhanced VEGF secretion and tube formation in endothelial cells and induced macrophage polarization from the M1 to the M2 phenotype, supporting tissue repair through both angiogenic and immunoregulatory pathways. This effect is attributed to ion-mediated regulation, where Cu2+ enhances VEGF expression via HIF-1α stabilization, while Zn2+ supports redox balance. Concurrently, Zn2+/Cu2+ shift macrophages toward the M2 phenotype, collectively establishing a pro-angiogenic and immunoregulatory niche. RNA sequencing further revealed that dECMMAZn/Cu significantly upregulated Lox, Loxl1-4, Sod1-3, and multiple Mmp family members, while activating key ECM homeostasis genes such as Adamts20, Eln, Col26a1, and Spp1. This transcriptional remodeling indicates a systematic reconstruction of the ion-enzyme-matrix network, restoring ECM plasticity and antioxidant capacity in aged follicles. ECM remodeling in this system is regulated rather than excessive, as supported by balanced transcriptional changes, enzyme-mediated matrix maturation, and anti-senescent cellular responses. In vivo, dECMMAZn/Cu microneedles effectively penetrated the stratum corneum and markedly restored follicular structural integrity and dermal collagen density in an androgenetic alopecia mouse model, thereby promoting robust hair regrowth. Immunofluorescence analysis confirmed re-expression of LOX and SOD1 around the follicles and within the dermal ECM, indicating reactivation of the Zn2+/Cu2+-dependent enzymatic network. Notably, although dECMMA alone showed a mild improvement compared with the AGA-treated Blank group, its effect was limited. The Sham and Blank groups represented physiological and pathological baselines, respectively. In contrast, dECMMAZn/Cu achieved markedly enhanced regeneration, indicating a synergistic effect of Zn2+/Cu2+ and dECM. Future studies will evaluate microneedle performance under varying skin mechanical conditions to better approximate clinical scalp environments. One limitation of this study is the use of both mouse- and human-derived cell models in vitro. Although the core processes investigated-ECM remodeling, macrophage polarization, and metal ion-dependent enzymatic regulation-are evolutionarily conserved, future validation using fully human-derived cells would further strengthen the translational relevance of these findings. The key contribution of this study is the proposal of a continuous regulatory axis: metal ions-protein conformation-enzymatic activity-microenvironment. Compared with conventional therapies such as minoxidil and finasteride, which primarily target vascular or hormonal pathways, the present system regulates the follicular microenvironment through enzymatic and ECM remodeling, providing a distinct mechanistic strategy for hair regeneration. Zn2+ and Cu2+ act not only as cofactors but also as conformational triggers that drive protein folding and activation. By constructing a dECMMA microneedle patches with controllable ion release, this study achieved precise reconstruction of the follicular enzymatic reservoir, overcoming the limitations of conventional therapies that target only hormonal or signaling pathways. Future research will focus on three aspects: (1) elucidating the dynamic regulation of ion homeostasis within hair follicles and identifying key transporters and metallochaperones; (2) employing multi-omics and spatial transcriptomics to characterize cell-type-specific responses to ionic signaling; and (3) optimizing ion release kinetics and dosage windows to achieve cyclic and controllable follicular regeneration. Alternative delivery strategies, including hydrogels, nanoparticles, and topical formulations, may also enable Zn2+/Cu2+ administration; however, they are often limited by insufficient penetration, rapid diffusion, or poor spatial control. In contrast, microneedle-based delivery provides localized and minimally invasive administration with enhanced retention. Nevertheless, microneedle patches may face limitations in coverage area for large-scale applications, which could be addressed through scalable design, repeated administration, or integration with complementary delivery systems. From a translational perspective, the ion-mediated regulation of enzymatic activity and microenvironmental homeostasis may be generalizable to other ECM-related degenerative conditions. Moreover, dECM-based microneedle systems can be manufactured using established micromolding techniques compatible with scalable and GMP-compliant production, although further optimization in standardization and regulatory validation is required. In conclusion, the dECMMAZn/Cu microneedle patches reactivate the follicular enzymatic reservoir and ECM homeostasis through ion-mediated protein conformational activation, significantly delaying stem cell aging and promoting hair regeneration. By targeting cofactor homeostasis, this work establishes a new paradigm of conformational activation for tissue regeneration, offering a translational strategy for treating follicular aging and other ECM-related degenerative disorders. Conclusion This study successfully reconstructed the enzymatic reservoir function of the hair follicle by developing a dual-ion-doped (Zn2+/Cu2+) decellularised extracellular matrix microneedle (dECMMAZn/Cu), providing an innovative therapeutic strategy for hair follicle regeneration and aging. Through ion-mediated activation of protein conformation, the microneedles not only restored the catalytic activity of Zn2+/Cu2+-dependent metalloproteases (such as LOX and SOD1), but also regulated the local microenvironment. This inhibited the expression of senescence markers (p16/p21) and promoted the proliferation and migration of HFSC. Furthermore, the microneedle system played a pivotal role in the regenerative regulation of HUVECs and macrophages, thereby promoting angiogenesis and immune homeostasis to further support tissue repair. In vivo experiments revealed that dECMMAZn/Cu microneedles significantly facilitated hair follicle structure recovery and hair growth, thus validating the potential of this strategy for hair follicle regeneration. By precisely controlling ion concentrations and conformational activation, this study provides a new approach for the treatment of hair follicle ageing and other matrix-related degenerative diseases. CRediT authorship contribution statement Shifeng Ling: Writing – original draft, Project administration, Investigation, Data curation. Mingyue Liu: Methodology, Investigation, Data curation. Chen Meng: Validation, Methodology, Formal analysis, Data curation. Kaifeng Huo: Software, Formal analysis, Data curation. Yida Wang: Visualization, Validation, Software. Yixiang Zhang: Methodology, Investigation. Yingying Wei: Validation, Formal analysis, Data curation. Lucia Zhou: Formal analysis, Data curation. Yawei Du: Writing – review & editing, Project administration, Methodology. Wenguo Cui: Writing – review & editing, Project administration, Funding acquisition, Conceptualization. AI usage statement During the preparation of this manuscript, the authors used ChatGPT (GPT-5, OpenAI) to assist with language refinement, including grammar correction and improvement of clarity and readability. The tool was not used to generate scientific ideas, analyze data, or draw conclusions. All text produced with AI assistance was critically reviewed and revised by the authors to ensure scientific accuracy and integrity. The authors take full responsibility for the final content of the manuscript. Ethics approval and consent to participate All animal husbandry and experiments were approved by the Animal Ethics Committee of Shanghai Songjiang District Chedun Experimental Animal Breeding Farm Co., Ltd (AD2022056) and strictly followed the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. Declarations of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.